Loss of p16Ink4a confers susceptibility to metastatic melanoma in mice

Paul Krimpenfort(Cancer Genomics Centre), Kim Quon(The Netherlands Cancer Institute), Wolter J. Mooi(The Netherlands Cancer Institute), Ate Loonstra(The Netherlands Cancer Institute), Anton Berns(Cancer Genomics Centre)

Nature

September 1, 2001

10.1038/35092584

Cited by 588

Abstract

Related Papers

CDK inhibitors: positive and negative regulators of G1-phase progression

Charles J. Sherr, Joanna Roberts|Genes & Development|1999|6.1k

Oncogenic ras Provokes Premature Cell Senescence Associated with Accumulation of p53 and p16INK4a

Manuel Serrano, Athena W. Lin, Mila E. McCurrach et al.|Cell|1997|5k

Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line

Jay P. Morgenstern, Hartmut Land|Nucleic Acids Research|1990|2.1k

Role of the INK4a Locus in Tumor Suppression and Cell Mortality

Manuel Serrano, Han‐Woong Lee, Lynda Chin et al.|Cell|1996|1.6k

Tumor Suppression at the Mouse INK4a Locus Mediated by the Alternative Reading Frame Product p19

Takehiko Kamijo, Frédérique Zindy, Martine F. Roussel et al.|Cell|1997|1.6k